These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3304918)

  • 21. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
    Eliopoulos GM; Wennersten CB; Moellering RC
    Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
    Westerman EL; Williams TW; Moreland N
    Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of MDL 62,879 against gram-positive bacteria and Bacteroides species.
    Bartoloni A; Mantella A; Goldstein BP; Denaro M; Nicoletti P; Paradisi F
    Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1105-8. PubMed ID: 8681991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
    Mraović M; Canić-Radojlović M
    Infection; 1986; 14 Suppl 4():S231-2. PubMed ID: 3469151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
    Chau PY; Leung YK; Ng WW
    Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-antibiotic effect induced by ofloxacin in both gram-positive and gram-negative bacteria.
    Reina S; Cavallero A; Debbia E
    Chemioterapia; 1988 Feb; 7(1):29-32. PubMed ID: 3163941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):30-3. PubMed ID: 2137413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
    J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
    Digranes A; Salveson A; Dibb WL
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):85-8. PubMed ID: 3728027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic potential of ofloxacin in hospital medicine. A French multicenter study].
    Carbon C; Delval C
    Pathol Biol (Paris); 1990 May; 38(5):397-400. PubMed ID: 2195449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
    Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
    Adeyemi-Doro FA; Rotowa NA
    Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of the new glycopeptide SK&F 104662 against problematic gram-positive bacteria.
    Soriano F; Zapardiel J; Fernández-Roblas R
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):782-4. PubMed ID: 1810738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
    Liu C; Wang ZQ; Li R; Sun XG
    Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):452-5. PubMed ID: 19576070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.